Baxter International (BAX) Stock Forecast & Price Target

$31.96 +0.26 (+0.82%)

(As of 11/15/2024 ET)

Baxter International - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Hold

Based on 11 Analyst Ratings

Sell
1

Hold
7

Buy
3

Based on 11 Wall Street analysts who have issued ratings for Baxter International in the last 12 months, the stock has a consensus rating of "Hold." Out of the 11 analysts, 1 has given a sell rating, 7 have given a hold rating, and 3 have given a buy rating for BAX.

Consensus Price Target

$40.91
28.00% Upside

According to the 11 analysts' twelve-month price targets for Baxter International, the average price target is $40.91. The highest price target for BAX is $54.00, while the lowest price target for BAX is $30.00. The average price target represents a forecasted upside of 28.00% from the current price of $31.96.

Get the Latest News and Ratings for BAX and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Baxter International and its competitors.

BAX Analyst Ratings Over Time

Type	Current Forecast 11/16/23 to 11/15/24	1 Month Ago 10/17/23 to 10/16/24	3 Months Ago 8/18/23 to 8/17/24	1 Year Ago 11/16/22 to 11/16/23
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	3 Buy rating(s)	2 Buy rating(s)	2 Buy rating(s)	4 Buy rating(s)
Hold	7 Hold rating(s)	8 Hold rating(s)	8 Hold rating(s)	8 Hold rating(s)
Sell	1 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$40.91	$42.00	$41.73	$47.25
Forecasted Upside	28.00% Upside	14.24% Upside	15.52% Upside	33.29% Upside
Consensus Rating	Hold	Hold	Hold	Hold

This Bull Market Indicator called NVDA at $116 (Ad)

Every now and again we find an investment idea so incredible we can’t help but share. And today is one of those rare days… Except, today we won't be giving you insight on any one particular stock… But rather, insight on a revolutionary new stock picking indicator… In fact, within the last year, this indicator has become famous for a multitude of reasons… But one of the biggest was because of the buy signal it issued on October 18th, 2022. In fact, on that very day, it said to buy NVDA at $116.37… Anyone who did would be sitting on a tremendously large return today… But even if you missed the original buy signal from October, this incredible indicator issued 11 other buy signals while Nvidia made its epic run…

All you have to do is follow this link here

BAX Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

BAX Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Baxter International Stock vs. The Competition

Type	Baxter International	Medical Companies	S&P 500
Consensus Rating Score	2.18	2.80	2.50
Consensus Rating	Hold	Moderate Buy	Moderate Buy
Predicted Upside	28.00% Upside	28,534.19% Upside	9.92% Upside
News Sentiment Rating	Neutral News See Recent BAX News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Action	Rating	Price Target	Upside/Downside on Report Date
11/11/2024	Stifel Nicolaus 4 of 5 stars	Lower Target	Buy ➝ Buy	$46.00 ➝ $38.00	+11.73%
10/1/2024	Citigroup 3 of 5 stars	Boost Target	Neutral ➝ Neutral	$38.00 ➝ $40.00	+8.40%
8/8/2024	The Goldman Sachs Group 2 of 5 stars	Boost Target	Neutral ➝ Neutral	$36.00 ➝ $40.00	+8.20%
8/7/2024	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Neutral ➝ Neutral	$44.00 ➝ $42.00	+13.61%
8/7/2024	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Equal Weight ➝ Equal Weight	$44.00 ➝ $40.00	+6.84%
7/15/2024	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Equal Weight ➝ Underweight	$39.00 ➝ $30.00	-15.06%
Get the Latest News and Ratings for BAX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Baxter International and its competitors with MarketBeat's FREE daily newsletter.
7/2/2024	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Outperform ➝ Outperform	$46.00 ➝ $45.00	+36.12%
5/10/2024	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Buy ➝ Hold	$40.00	+11.27%
3/5/2024	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Neutral ➝ Neutral	$42.00 ➝ $45.00	+2.93%
2/12/2024	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Overweight ➝ Overweight	$52.00 ➝ $54.00	+35.71%
2/6/2024	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Neutral ➝ Neutral	$40.00 ➝ $36.00	-8.28%
10/24/2023	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Hold ➝ Hold	$35.00 ➝ $50.00	+52.72%
7/31/2023	KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Overweight	$53.00 ➝ $51.00	+8.49%
5/30/2023	888 Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Assumes
2/10/2023	Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Outperform	$70.00 ➝ $45.00	+12.11%
1/5/2023	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Outperform ➝ Market Perform

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 12:35 AM ET.

Should I Buy Baxter International Stock? BAX Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Monday, November 4, 2024. Please send any questions or comments about these Baxter International pros and cons to contact@marketbeat.com.

Baxter International
Bull Case

Here are some ways that investors could benefit from investing in Baxter International Inc.:

Baxter International Inc. has a current stock price of $37.12, which may present a buying opportunity for investors looking for value stocks.
The company reported a return on equity of 18.06%, indicating efficient utilization of shareholder equity to generate profits.
Baxter International Inc. has a dividend yield of 3.13%, providing investors with a steady income stream.
The company's revenue was up 2.8% on a year-over-year basis, showing growth potential in its business operations.
Baxter International Inc. beat analysts' earnings estimates, demonstrating strong financial performance and management execution.

Baxter International
Bear Case

Investors should be bearish about investing in Baxter International Inc. for these reasons:

The company has a debt-to-equity ratio of 1.35, which indicates a relatively high level of debt compared to equity, posing financial risk.
Baxter International Inc. has a quick ratio of 0.91, suggesting potential liquidity challenges in meeting short-term obligations.
Analysts have issued mixed ratings on the stock, with some downgrades and price target reductions, signaling uncertainty in the market regarding the company's future performance.
The company's payout ratio is 22.31%, which may limit future growth opportunities or reinvestment in the business.
Market conditions and competitive pressures in the healthcare industry could impact Baxter International Inc.'s profitability and market position.

BAX Forecast - Frequently Asked Questions

: According to the research reports of 11 Wall Street equities research analysts, the average twelve-month stock price forecast for Baxter International is $40.91, with a high forecast of $54.00 and a low forecast of $30.00.
: 11 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Baxter International in the last year. There is currently 1 sell rating, 7 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" BAX shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in BAX, but not buy additional shares or sell existing shares.
: According to analysts, Baxter International's stock has a predicted upside of 28.00% based on their 12-month stock forecasts.
: Baxter International has been rated by research analysts at Citigroup, and Stifel Nicolaus in the past 90 days.
: Analysts like Baxter International less than other "medical" companies. The consensus rating for Baxter International is Hold while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how BAX compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top Rated Stocks

More Ratings Tools

Buffett’s Selling Out: Is Your 401(k) About to Get Wiped Out? (Ad)

Let me share something important with you. Just a few weeks ago, Warren Buffett unloaded $932 million worth of bank stocks. He didn't do it on a whim—he knows something big is coming. The question is: Why aren't you taking action, too?

Click Here For Your Free Guide

This page (NYSE:BAX) was last updated on 11/15/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Baxter International (BAX) Stock Forecast & Price Target